Estimation of organ and effective doses of CBCT scans of radiotherapy using size-specific field of view (FOV): a Monte Carlo study.

The kV cone beam computed tomography (CBCT) is one of the most common imaging modalities used for image-guided radiation therapy (IGRT) procedures. Additional doses are delivered to patients, thus assessment and optimization of the imaging doses should be taken into consideration. This study aimed to investigate the influence of using fixed and patient-specific FOVs on the patient dose. Monte Carlo simulations were performed to simulate kV beams of the imaging system integrated into Truebeam linear accelerator using BEAMnrc code. Organ and size-specific effective doses resulting from chest and pelvis scanning protocols were estimated with DOSXYZnrc code using a phantom library developed by the National Cancer Institute (NCI) of the US. The library contains 193 (100 male and 93 female) mesh-type computational human adult phantoms, and it covers a large ratio of patient sizes with heights and weights ranging from 150 to 190 cm and 40 to 125 kg. The imaging doses were assessed using variable FOV of three sizes, small (S), medium (M), and large (L) for each scan region. The results show that the FOV and the patient size played a major role in the scan dose. The average percentage differences (PDs) for doses of organs that were fully inside the different FOVs were relatively low, all within 11% for both protocols. However, doses to organs that were scanned partially or near the FOVs were affected significantly. For the chest protocol, the inclusion of the thyroid in the scan field could give a dose of 1-7 mGy/100 mAs to the thyroid, compared to 0.4-1 mGy/100 mAs when it was excluded. Similarly, on average, testes doses could be 6 mGy/100 mAs for the male pelvis protocol compared to 3 mGy/100 mAs when it did not lie in the field irradiated. These dose differences resulted in an average increase of up to 27% in the size-specific effective dose of the protocols. Since changing the field size is possible for CBCT scans, the results suggest that patient-specific scanning protocols could be applied for each scan area in a manner similar to that used for CT scans. Adjustment of the FOV size should be subject to the clinical needs, and assist in improving the treatment accuracy. The patient's height and weight might be considered as the main factors upon which, the selection of the appropriate patient-specific protocol is based. This approach should optimize the imaging doses used for IGRT procedures by minimizing doses of a large ratio of patients.

Estimation of size-specific dose estimate (SSDE) of CT scans using an effective diameter electron density.

OBJECTIVE: An assessment of the effective diameter of a patient's body using electron densities of tissues inside the scan area (Deffρe) was proposed to overcome challenges associated with the estimation of water-equivalent diameter (Dw), which is used for size-specific dose estimate (SSDE). The aims of this study were to (1) investigate the Deffρe method in two different forms using a wide range of patient sizes and scanning protocols, and (2) compare between four methods used to estimate the patient size for SSDE. MATERIALS AND METHODS: Under IRB approval, a total of 350 patients of varying sizes have been collected retrospectively from the Hospital. The Dw values were assessed over six different CT body protocols: (1) chest with contrast media, (2) chest High-Resolution Computed Tomography (HRCT) without contrast media, (3) abdomen-pelvis with contrast media, (4) abdomen-pelvis without contrast media, (5) chest-abdomen-pelvis with contrast media, and (6) pelvis without contrast media. A MATLAB-based code was developed in-house to assess the size of each patient using the conventional effective diameter method (Deff), Deffρe by correcting either both the lateral (LAT) and anterior-posterior (AP) dimensions (Deff,LAT+APρe) or LAT only (Deff,LATρe), and Dw at the mid-CT slice of the patient images. RESULTS: The results of Deff,LAT+APρe and Deff,LATρe provided a better estimation for the chest protocols with the averages of absolute percentage difference (PD) values in the range of 3 - 7 % for all patient sizes as compared to the Dw method, whereas the averages of PD values for the Deff method were 9 - 15 %. However, Deff gave a better estimation for Dw values for the other body protocols, with differences of 2 - 4 %, which were lower than those obtained with the Deff,LAT+APρe and Deff,LATρe methods. For the chest protocols, statistically significant differences were found between Deff and the other methods, but there were no significant differences between all the methods for the other scanning protocols. The results show that the correction of both dimensions, LAT and AP, did not improve the accuracy of the Deffρe method, and, for most protocols, Deff,LAT+APρe gave larger range differences compared to those based on correction of the LAT dimension only. CONCLUSION: If the Dw cannot be assessed, the Deff,LATρe method may only be considered for the chest protocols as an alternative approach. The Deff method may also be used for all regions taking into account the application of a correction factor for the chest protocols to avoid a significant under or overestimation of the patient dose.

Dose quantities for measurement and comparison of doses to individual patients in computed tomography (CT).

The dose quantities displayed routinely on CT scanners, the volume averaged CT dose index (CTDIvol) and dose length product, provide measures of doses calculated for standard phantoms. The American Association of Medical Physics has published conversion factors for the adjustment of CTDIvolto take account of variations in patient size, the results being termed size-specific dose estimate (SSDE). However, CTDIvoland SSDE, while useful in comparing and optimising doses from a set procedure, do not provide risk-related information that takes account of the organs and tissues irradiated and associated cancer risks. A derivative of effective dose that takes account of differences in body and organ sizes and masses, referred to here as size-specific effective dose (SED), can provide such information. Data on organ doses from NCICT software that is based on Monte Carlo simulations of CT scans for 193 adult phantoms have been used to compute values of SED for CT examinations of the trunk and results compared with corresponding values of SSDE. Relationships within ±8% were observed between SED and SSDE for scans extending over similar regions for phantoms with a wide range of sizes. Coefficients have been derived from fits of the data to estimate SED values from SSDEs for different regions of the body for scans of standard lengths based on patient height. A method developed to take account of differences in scan length gave SED results within ±5% of values calculated using the NCI phantom library. This approach could potentially be used to estimate SED from SSDE values, allowing their display at the time a CT scan is performed.

Estimation of size-specific dose estimates (SSDE) for paediatric and adults patients based on a single slice.

Volume averaged CT dose index (CTDIvol) is an important dose index utilized for CT dosimetry. Measurements of CTDIvol are performed in reference cylindrical phantoms of specified diameters. A size-specific dose estimate (SSDE) has been recommended for assessment of doses delivered to individual patients. Evaluation of the SSDE requires the size of the scanned region of the patient to be estimated in terms of water-equivalent diameter (Dw) to allow calculation of a dose value appropriate for the patient. Estimation of Dw, however, may be challenging and time consuming as it requires assessment of Dw for each slice within the scanned region. A study has been carried out to investigate the suitability of using Dw,mid for a single slice at the middle of the scanned region to estimate a value of Dw,mean to apply to all slices. 351 phantoms (158 paediatric and 193 adult) developed from reconstructed CT images of patients were employed. Six scan regions were studied: chest, abdomen, pelvis, chest and abdomen, abdomen and pelvis, and the whole trunk. Results show that the use of Dw,mid can lead to over or underestimation of Dw,mean by up to 13% for paediatric and adult patients. SSDE values based on Dw,mid and Dw,mean were assessed for each phantom, and a linear regression analysis was performed. Use of the analysis could provide a simple and practical approach to assessing SSDE for a given scan based on Dw,mid with the root-mean-square errors estimated to be in the range of 1.2%-4.0% for paediatric and 1.2%-5.9% for adults.

A Monte Carlo investigation of dose length product of cone beam computed tomography scans.

The dose length product (DLP) provides a measurement related to energy imparted from a computed tomography (CT) scan. The DLP is based on the volume-averaged CT dose index (CTDI vol), which is designed for fan beams. The aims of this study were to investigate the use of DLP for scans with wide beams used in cone beam CT (DLP CBCT) in radiotherapy that would be analogous to the DLP of fan beam scans (DLP CT), and to compare the efficiencies of DLP CT and DLP CBCT in reporting the total energy imparted in patients. A validated Monte Carlo model of a kV imaging system integrated into a Varian TrueBeam linac was employed. The DLP CT was assessed by multiplying the CTDI vol for a 20 mm fan beam by scan length, and the DLP CBCT determined through multiplying the CTDI vol, estimated for wide beams using a correction factor based on free-in-air measurements, by the beam width. Two scan protocols for head and body were investigated for tube potentials between 80 and 140 kV and a range of scan lengths/widths. Efficiency values were estimated by normalising the DLP CT and DLP CBCT with respect to the corresponding dose profile integrals (DPIs), which were evaluated within 900 mm long phantoms. The results show that the DLP CBCT values were within 1% of those for DLP CT of similar length performed on the same system, and the efficiencies decrease with tube potential. However, whereas DLP values for fan beams are approximately proportional to scan length, those for wide beams decrease by ∼2% between beam widths of 20 and 320 mm. As a result, while the DLP CT efficiency is similar over all scan lengths, that for DLP CBCT increases slightly with beam width. The DLP CT and DLP CBCT underestimated the total energy imparted by comparable amounts with efficiencies within the range of 80-81% and 80-83% for the head scans, and 71-76% and 70-77% for the body scans, respectively. The results indicate that the DLP CBCT can be considered as an analogous dose index to the DLP CT. It could, therefore, be used for quantification of doses from imaging in radiotherapy and provide a valuable tool to aid optimisation.

Influence of cone beam CT (CBCT) scan parameters on size specific dose estimate (SSDE): a Monte Carlo study.

The CT dose index (CTDIvol) is the dosimetric quantity used for multi-slice CT (MSCT) with beams ⩽4 cm. Conversion factors (f size) based on patient size are applied to CTDIvol to adjust for differences in patient size and derive size-specific dose estimates (SSDE) relating to patient dose. The aim of this study is to: (1) investigate use of a similar technique to provide SSDE values for cone beam CT (CBCT) scans, (2) determine whether factors derived for narrow beam MSCT are suitable for CBCT, and (3) investigate the influence of CBCT parameters on f size values. Monte Carlo simulations were used to model an on-board imager system integrated into a Varian Truebeam linear accelerator, and to assess doses for imaging. The CTDIvol is unsuitable for CBCT dosimetry, thus the assessments were applied to the modification CTDIIEC, recommended by the international electrotechnical commission (IEC). Conversion factors (f size,CBCT) were derived for CBCT to allow adjustment of values for the absorbed dose in water (AD) averaged over the beam width in the middle of the phantoms. Values of AD were evaluated as for CTDI300 measured with a 30 cm long chamber in centres and peripheries of long water phantoms with diameters of 10-40 cm for head and body protocols. Three beam widths 8, 16, and 24 cm were used with tube potentials ranging from 80-140 kV, for full and partial rotation modes. In order to derive f size,CBCT values, calculated values for AD were normalized with respect to the weighted CTDIIEC assessed in standard CTDI phantoms and free-in-air. Variations in f size,CBCT with beam width were minimal, 1%-5%, but those with tube potential were greater for 80 kV at small diameters reaching 11%. Acquisition mode affected f size,CBCT values by up to 7%. Best-fit curves were derived from the f size,CBCT values and compared to those reported by AAPM TG-204 for MSCT. Conversion factors estimated from these curves for 120 kV were within ±8% and ±13% of the MSCT values over head and body diameters, respectively, representing the majority of the adult population. Therefore, the use of MSCT factors to convert CTDIIEC for CBCT scans may lead to under/overestimation of doses to patients by 5% and 6%, on average, for the head and body protocols, respectively. Best-fit curves of the results from this study provide values that could be used to convert CTDIIEC for specific water-equivalent diameter (D w) to a SSDE.

Evaluation of coefficients to derive organ and effective doses from cone-beam CT (CBCT) scans: a Monte Carlo study.

Regular imaging is used throughout image guided radiation therapy to improve treatment delivery. In order for treatment procedures to be optimized, the doses delivered by imaging exposures should be taken into account. CT dosimetry methods based on the CT dose index (CTDI), measured with a 100 mm long pencil ionization chamber (CTDI100) in standard phantoms, are not designed for cone-beam CT (CBCT) imaging systems used in radiotherapy, therefore a modified version has been proposed for CBCT by the International Electrotechnical Commission (CTDIIEC). Monte Carlo simulations based on a Varian On-Board Imaging system were used to derive conversion coefficients that enable organ doses for ICRP reference phantoms to be determined from the CTDIIEC for different scan protocols and different beam widths (80-320) mm. A dose-width product calculated by multiplying the CTDIIEC by the width of the CBCT beam is proposed as a quantity that can be used for estimating effective dose. The variation in coefficients with CBCT beam width was studied. Coefficients to allow estimation of effective doses were derived, namely 0.0034 mSv (mGy cm)-1 for the head, 0.0252 mSv (mGy cm)-1 for the thorax, 0.0216 mSv (mGy cm)-1 for the abdomen and 0.0150 mSv (mGy cm)-1 for the pelvis, and these may be applicable more generally to other CBCT systems in radiotherapy. If data on effective doses are available, these can be used in making judgements on the contributions to patient dose from imaging, and thereby assist in optimization of the treatment regimes. The coefficients can also be employed in converting dosimetry data recorded in patient records into quantities relating directly to patient doses.

A Monte Carlo study of organ and effective doses of cone beam computed tomography (CBCT) scans in radiotherapy.

Cone-beam CT (CBCT) scans utilised for image guided radiation therapy (IGRT) procedures have become an essential part of radiotherapy. The aim of this study was to assess organ and effective doses resulting from new CBCT scan protocols (head, thorax, and pelvis) released with a software upgrade of the kV on-board-imager (OBI) system. Organ and effective doses for protocols of the new software (V2.5) and a previous version (V1.6) were assessed using Monte Carlo (MC) simulations for the International Commission on Radiological Protection (ICRP) adult male and female reference computational phantoms. The number of projections and the mAs values were increased and the size of the scan field was extended in the new protocols. Influence of these changes on organ and effective doses of the scans was investigated. The OBI system was modelled in EGSnrc/BEAMnrc, and organ doses were estimated using EGSnrc/DOSXYZnrc. The MC model was benchmarked against experimental measurements. Organ doses resulting from the V2.5 protocols were higher than those of V1.6 for organs that were partially or fully inside the scans fields, and increased by (3-13)%, (10-77)%, and (13-21)% for the head, thorax, and pelvis protocols for both phantoms, respectively. As a result, effective doses rose by 14%, 17%, and 16% for the male phantom, and 13%, 18%, and 17% for the female phantom for the three scan protocols, respectively. The scan field extension for the V2.5 protocols contributed significantly in the dose increases, especially for organs that were partially irradiated such as the thyroid in head and thorax scans and colon in the pelvic scan. The contribution of the mAs values and projection numbers was minimal in the dose increases, up to 2.5%. The field size extension plays a major role in improving the treatment output by including more markers in the field of view to match between CBCT and CT images and hence setting up the patient precisely. Therefore, a trade-off between the risk and benefits of CBCT scans should be considered, and the dose increases should be monitored. Several recommendations have been made for optimisation of the patient dose involved for IGRT procedures.

Organ doses can be estimated from the computed tomography (CT) dose index for cone-beam CT on radiotherapy equipment.

Cone beam computed tomography (CBCT) systems are fitted to radiotherapy linear accelerators and used for patient positioning prior to treatment by image guided radiotherapy (IGRT). Radiotherapists' and radiographers' knowledge of doses to organs from CBCT imaging is limited. The weighted CT dose index for a reference beam of width 20 mm (CTDIw,ref) is displayed on Varian CBCT imaging equipment known as an On-Board Imager (OBI) linked to the Truebeam linear accelerator. This has the potential to provide an indication of organ doses. This knowledge would be helpful for guidance of radiotherapy clinicians preparing treatments. Monte Carlo simulations of imaging protocols for head, thorax and pelvic scans have been performed using EGSnrc/BEAMnrc, EGSnrc/DOSXYZnrc, and ICRP reference computational male and female phantoms to derive the mean absorbed doses to organs and tissues, which have been compared with values for the CTDIw,ref displayed on the CBCT scanner console. Substantial variations in dose were observed between male and female phantoms. Nevertheless, the CTDIw,ref gave doses within ±21% for the stomach and liver in thorax scans and 2 × CTDIw,ref can be used as a measure of doses to breast, lung and oesophagus. The CTDIw,ref could provide indications of doses to the brain for head scans, and the colon for pelvic scans. It is proposed that knowledge of the link between CTDIw for CBCT should be promoted and included in the training of radiotherapy staff.

Evaluation of cumulative dose for cone-beam computed tomography (CBCT) scans within phantoms made from different compositions using Monte Carlo simulations.

Measurement of cumulative dose ƒ(0,150) with a small ionization chamber within standard polymethyl methacrylate (PMMA) CT head and body phantoms, 150 mm in length, is a possible practical method for cone-beam computed tomography (CBCT) dosimetry. This differs from evaluating cumulative dose under scatter equilibrium conditions within an infinitely long phantom ƒ(0,∞), which is proposed by AAPM TG-111 for CBCT dosimetry. The aim of this study was to investigate the feasibility of using ƒ(0,150) to estimate values for ƒ(0,∞) in long head and body phantoms made of PMMA, polyethylene (PE), and water, using beam qualities for tube potentials of 80-140 kV. The study also investigated the possibility of using 150 mm PE phantoms for assessment of ƒ(0,∞) within long PE phantoms, the ICRU/AAPM phantom. The influence of scan parameters, composition, and length of the phantoms was investigated. The capability of ƒ(0,150) to assess ƒ(0,∞) has been defined as the efficiency and assessed in terms of the ratios ε(ƒ(0,150) / ƒ(0,∞)). The efficiencies were calculated using Monte Carlo simulations for an On-Board Imager (OBI) system mounted on a TrueBeam linear accelerator. Head and body scanning protocols with beams of width 40-500 mm were used. Efficiencies ε(PMMA/PMMA) and ε(PE/PE) as a function of beam width exhibited three separate regions. For beam widths < 150 mm, ε(PMMA/PMMA) and ε(PE/PE) values were greater than 90% for the head and body phantoms. The efficiency values then fell rapidly with increasing beam width before levelling off at 74% for ε(PMMA/PMMA) and 69% for ε(PE/PE) for a 500 mm beam width. The quantities ε(PMMA/PE) and ε(PMMA/Water) varied with beam width in a different manner. Values at the centers of the phantoms for narrow beams were lower and increased to a steady state for ~100-150 mm wide beams, before declining with increasing the beam width, whereas values at the peripheries decreased steadily with beam width. Results for ε(PMMA/PMMA) were virtually independent of tube potential, but there was more variation for ε(PMMA/PE) and ε(PMMA/Water). ƒ(0,150) underestimated ƒ(0,∞) for beam widths used for CBCT scans, thus it is necessary to use long phantoms, or apply conversion factors (Cƒs) to measurements with standard PMMA CT phantoms. The efficiency values have been used to derive (Cƒs) to allow evaluation of ƒ(0,∞) from measurements of ƒ(0,150). The (Cƒs) only showed a weak dependence on scan parameters and scanner type, and so may be suitable for general application.

Investigation of practical approaches to evaluating cumulative dose for cone beam computed tomography (CBCT) from standard CT dosimetry measurements: a Monte Carlo study.

A function called Gx(L) was introduced by the International Commission on Radiation Units and Measurements (ICRU) Report-87 to facilitate measurement of cumulative dose for CT scans within long phantoms as recommended by the American Association of Physicists in Medicine (AAPM) TG-111. The Gx(L) function is equal to the ratio of the cumulative dose at the middle of a CT scan to the volume weighted CTDI (CTDIvol), and was investigated for conventional multi-slice CT scanners operating with a moving table. As the stationary table mode, which is the basis for cone beam CT (CBCT) scans, differs from that used for conventional CT scans, the aim of this study was to investigate the extension of the Gx(L) function to CBCT scans. An On-Board Imager (OBI) system integrated with a TrueBeam linac was simulated with Monte Carlo EGSnrc/BEAMnrc, and the absorbed dose was calculated within PMMA, polyethylene (PE), and water head and body phantoms using EGSnrc/DOSXYZnrc, where the body PE body phantom emulated the ICRU/AAPM phantom. Beams of width 40-500 mm and beam qualities at tube potentials of 80-140 kV were studied. Application of a modified function of beam width (W) termed Gx(W), for which the cumulative dose for CBCT scans f (0) is normalized to the weighted CTDI (CTDIw) for a reference beam of width 40 mm, was investigated as a possible option. However, differences were found in Gx(W) with tube potential, especially for body phantoms, and these were considered to be due to differences in geometry between wide beams used for CBCT scans and those for conventional CT. Therefore, a modified function Gx(W)100 has been proposed, taking the form of values of f (0) at each position in a long phantom, normalized with respect to dose indices f 100(150)x measured with a 100 mm pencil ionization chamber within standard 150 mm PMMA phantoms, using the same scanning parameters, beam widths and positions within the phantom. f 100(150)x averages the dose resulting from a CBCT scan over the 100 mm length. Like the Gx(L) function, the Gx(W)100 function showed only a weak dependency on tube potential at most positions for the phantoms studied. The results were fitted to polynomial equations from which f (0) within the longer PMMA, PE, or water phantoms can be evaluated from measurements of f 100(150)x. Comparisons with other studies, suggest that these functions may be suitable for application to any CT or CBCT scan acquired with stationary table mode.

A Monte Carlo investigation of cumulative dose measurements for cone beam computed tomography (CBCT) dosimetry.

Many studies have shown that the computed tomography dose index (CTDI100) which is considered as a main dose descriptor for CT dosimetry fails to provide a realistic reflection of the dose involved in cone beam computed tomography (CBCT) scans. Several practical approaches have been proposed to overcome drawbacks of the CTDI100. One of these is the cumulative dose concept. The purpose of this study was to investigate four different approaches based on the cumulative dose concept: the cumulative dose (1) f(0,150) and (2) f(0,∞) with a small ionization chamber 20 mm long, and the cumulative dose (3) f100(150) and (4) f100(∞) with a standard 100 mm pencil ionization chamber. The study also aimed to investigate the influence of using the 20 and 100 mm chambers and the standard and the infinitely long phantoms on cumulative dose measurements. Monte Carlo EGSnrc/BEAMnrc and EGSnrc/DOSXYZnrc codes were used to simulate a kV imaging system integrated with a TrueBeam linear accelerator and to calculate doses within cylindrical head and body PMMA phantoms with diameters of 16 cm and 32 cm, respectively, and lengths of 150, 600, 900 mm. f(0,150) and f100(150) approaches were studied within the standard PMMA phantoms (150 mm), while the other approaches f(0,∞) and f100(∞) were within infinitely long head (600 mm) and body (900 mm) phantoms. CTDI∞ values were used as a standard to compare the dose values for the approaches studied at the centre and periphery of the phantoms and for the weighted values. Four scanning protocols and beams of width 20-300 mm were used. It has been shown that the f(0,∞) approach gave the highest dose values which were comparable to CTDI∞ values for wide beams. The differences between the weighted dose values obtained with the 20 and 100 mm chambers were significant for the beam widths <120 mm, but these differences declined with increasing beam widths to be within 4%. The weighted dose values calculated within the infinitely long phantoms with both the chambers for the beam widths ≤140 were within 3% of those within the standard phantoms, but the differences rose to be within 15% at wider beams. By comparing the approaches studied in this investigation with other methodologies taking into account the efficiency of the approach as a dose descriptor and the simplicity of the implementation in the clinical environment, the f(0,150) method may be the best for CBCT dosimetry combined with the use of correction factors.

An assessment of the efficiency of methods for measurement of the computed tomography dose index (CTDI) for cone beam (CBCT) dosimetry by Monte Carlo simulation.

The IEC has introduced a practical approach to overcome shortcomings of the CTDI100 for measurements on wide beams employed for cone beam (CBCT) scans. This study evaluated the efficiency of this approach (CTDIIEC) for different arrangements using Monte Carlo simulation techniques, and compared CTDIIEC to the efficiency of CTDI100 for CBCT. Monte Carlo EGSnrc/BEAMnrc and EGSnrc/DOSXYZnrc codes were used to simulate the kV imaging system mounted on a Varian TrueBeam linear accelerator. The Monte Carlo model was benchmarked against experimental measurements and good agreement shown. Standard PMMA head and body phantoms with lengths 150, 600, and 900 mm were simulated. Beam widths studied ranged from 20-300 mm, and four scanning protocols using two acquisition modes were utilized. The efficiency values were calculated at the centre (εc) and periphery (εp) of the phantoms and for the weighted CTDI (εw). The efficiency values for CTDI100 were approximately constant for beam widths 20-40 mm, where εc(CTDI100), εp(CTDI100), and εw(CTDI100) were 74.7 ± 0.6%, 84.6 ± 0.3%, and 80.9 ± 0.4%, for the head phantom and 59.7 ± 0.3%, 82.1 ± 0.3%, and 74.9 ± 0.3%, for the body phantom, respectively. When beam width increased beyond 40 mm, ε(CTDI100) values fell steadily reaching ~30% at a beam width of 300 mm. In contrast, the efficiency of the CTDIIEC was approximately constant over all beam widths, demonstrating its suitability for assessment of CBCT. εc(CTDIIEC), εp(CTDIIEC), and εw(CTDIIEC) were 76.1 ± 0.9%, 85.9 ± 1.0%, and 82.2 ± 0.9% for the head phantom and 60.6 ± 0.7%, 82.8 ± 0.8%, and 75.8 ± 0.7%, for the body phantom, respectively, within 2% of ε(CTDI100) values for narrower beam widths. CTDI100,w and CTDIIEC,w underestimate CTDI∞,w by ~55% and ~18% for the head phantom and by ~56% and ~24% for the body phantom, respectively, using a clinical beam width 198 mm. The CTDIIEC approach addresses the dependency of efficiency on beam width successfully and correction factors have been derived to allow calculation of CTDI∞.